NOTV
Inotiv, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.08
+121.94%Price chart
Jun 2Jun 5Jun 10Jun 15Jun 18Jun 24Jun 29Jul 2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
46.6x
Market Cap
$2.79M
MomentumView details →
1D Return
+121.94%
YTD Return
−98.04%
RSI (14)
27.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
46.6x
Market Cap
$2.79M
RSI (14)
27.6
MomentumView details →
1D Return
+121.94%
YTD Return
−98.04%
SummaryUpdated Mar 1, 2026
Inotiv, Inc. (NASDAQ:NOTV) is a contract research organization founded in 1974 and headquartered in West Lafayette, Indiana. Originally known as Bioanalytical Systems, Inc., the company rebranded to Inotiv in March 2021. The company provides comprehensive drug discovery and development services to pharmaceutical, biotechnology, chemical, and medical device companies worldwide. Through strategic acquisitions and organic growth over the past several years, Inotiv has evolved from a specialized analytical instruments manufacturer into a full-service contract research organization offering both testing services and research products across the drug development lifecycle.
Similar companies
Latest newsMore news →
Inotiv, Inc. filed for Chapter 11 bankruptcy in the United States Bankruptcy Court for the Southern District of Texas, Houston Division.51d agoInotiv entered into a Restructuring Support Agreement with its creditors to strengthen its capital structure.93d agoInotiv, Inc. amended the indenture governing its $140 million 3.25% Convertible Senior Notes due 2027 to extend the grace period for missed interest payments from 44 to 51 days.96d ago